Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lentigen receives NIH grant to develop melanoma immunotherapy

Aug. 11, 2010

New alpha-mannosidase inhibitors identified by Emory University

Aug. 11, 2010

Daiichi Sankyo claims new Mdm2-p53 interaction inhibitors

Aug. 11, 2010

European researchers describe new Aurora kinase A inhibitors

Aug. 10, 2010

SNS-032 shows moderate activity in phase I trial in B-cell malignancies

Aug. 10, 2010

Curis provides update on phase II vismodegib trial in advanced ovarian cancer

Aug. 10, 2010

Aragon doses first patient in phase I/II ARN-509 trial in prostate cancer

Aug. 10, 2010

Cannabidiol displays antiangiogenic activity in preclinical tests

Aug. 10, 2010

Sunesis partners for phase III VALOR trial of vosaroxin in AML

Aug. 9, 2010

FDA does not grant orphan drug status to Levulan PDT for SCC prevention

Aug. 9, 2010

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...